TGFB1 and neoplasm: In a univariate analysis (Table 3), clinical T4 disease (p = 0.007), stage ≥ IV (p = 0.031), and persistently high sMICA and TGF-β1 levels (p = 0.030) were significantly associated with tumor progression; these factors were significantly associated with death.